Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Wu, De-Pei  [Clear All Filters]
Journal Article
Tao T, Li Z, Chu X-L, Zhu W-J, Xu Y, Wu D-P, Ma X, Xue S-L. Clinical features of chronic graft-versus-host disease following haploidentical transplantation combined with infusion of a cord blood. Stem Cells Dev. 2019.
Zhang Y-Q, Wu W-Q, Xu J, Tang Z-X, Li S-J, Li L, Wu H-Q, Ma X, Liu J-S, Wu D-P, et al. A clinical predictive model for pre-transplantation colonization and relevance for clinical outcomes in patients receiving allogeneic hematopoietic stem cell transplantation. Microbiol Spectr. 2024:e0203923.
Yan C-H, Liu Q-F, Wu D-P, Zhang X, Xu L-P, Zhang X-H, Wang Y, Huang H, Bai H, Huang F, et al. Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor. Biol Blood Marrow Transplant. 2019.
Zhu X-F, He H-L, Wang S-Q, Tang J-Y, Han B, Zhang D-H, Wu L-Q, Wu D-P, Li W, Xia L-H, et al. Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study. Acta Haematol. 2019:1-9.
Xie Y, Yan L-Z, You T, Shi X-L, Yan S, Zhai Y-Y, Shang J-J, Yan Z, You H-Y, Wang Q-Q, et al. [Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024;32(2):505-511.
Xu L-P, Wang S-Q, Wu D-P, Wang J-M, Gao S-J, Jiang M, Wang C-B, Zhang X, Liu Q-F, Xia L-H, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016.
Xu L-P, Lu D-P, Wu D-P, Jiang E-L, Liu D-H, Huang H, Sun Z-M, Li N-N, Liu Q-F, Zhang X, et al. Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Transplant Cell Ther. 2022.
Xue S-L, Cui H-X, Zou J-Y, Xue M-X, Tang X-W, Zhang Y-M, Wu D-P. Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients. Hematol Oncol. 2013.
Wang Y, Liu Q-F, Wu D-P, Xu Z-L, Han T-T, Sun Y-Q, Huang F, Fan Z-P, Xu N, Chen F, et al. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. BMC Med. 2024;22(1):176.
Wu W-Q, Zhang Y-Q, Xu J, Tang Z-X, Li S-J, Wei X-Y, Li L, Wu H-Q, Ma X, Liu J-S, et al. Risk Factors for Carbapenem-Resistant Colonization and the Effect on Clinical Outcomes and Prognosis in Allogeneic Hematopoietic Stem Cell Transplanted Patients. Infect Drug Resist. 2023;16:6821-6831.
Wang X-Y, Bian M-R, Lin G-Q, Yu L, Zhang Y-M, Wu D-P. Tandem bispecific CD123/CLL-1 CAR-T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia. Eur J Haematol. 2023.
Cheng W-Y, Li J-F, Zhu Y-M, Lin X-J, Wen L-J, Zhang F, Zhang Y-L, Zhao M, Fang H, Wang S-Y, et al. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. Proc Natl Acad Sci U S A. 2022;119(49):e2211429119.
Dai Y-T, Zhang F, Fang H, Li J-F, Lu G, Jiang L, Chen B, Mao D-D, Liu Y-F, Wang J, et al. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases. Proc Natl Acad Sci U S A. 2022;119(15):e2120787119.